Comparison of treatment costs for primary localized prostate cancer in Austria and Vienna: an economic analysis.

ABSTRACT:

Background

Prostate cancer is the most common cancer in men. Several efficient treatments are available for primary prostate cancer, but an economic comparison of these modalities has not been done in Austria.

Objective and setting

The current study provides an economic comparison of radiotherapy and surgery for prostate cancer in Vienna and Austria.

Methods

We analyzed the catalog of medical services of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection and present the treatment costs for the public health sector with an LKF-point value and monetary value in 2022.

Results

External beam radiotherapy, especially ultrahypofractionated, is the least costly treatment modality for low-risk prostate cancer, with costs of 2,492 € per

SUBMITTER: Moll M 

PROVIDER: S-EPMC10267377 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature